This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Corporation. Active years: 1981.
Company Filing History:
Years Active: 1981
Title: The Innovations of Robert D Krell
Introduction
Robert D Krell is a notable inventor based in Medford, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiallergic compounds. His work has led to the creation of innovative solutions for treating allergic conditions.
Latest Patents
Robert D Krell holds a patent for "Antiallergic imidodisulfamides." This patent involves the preparation of imidodisulfamide derivatives that are useful in treating allergic conditions. The process includes the reaction of an appropriately substituted primary amine and bis(chlorosulfonyl) imide in the presence of a tertiary amine. This innovative approach has the potential to improve the quality of life for individuals suffering from allergies.
Career Highlights
Throughout his career, Robert has been associated with SmithKline Corporation, where he has contributed to various research and development projects. His expertise in chemistry and pharmacology has been instrumental in advancing the company's product offerings.
Collaborations
Robert has worked alongside talented colleagues, including Fadia E Ali and Kenneth M Snader. Their collaborative efforts have fostered a productive research environment, leading to significant advancements in their field.
Conclusion
Robert D Krell's contributions to the field of pharmaceuticals, particularly through his patent on antiallergic imidodisulfamides, highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to inspire future advancements in allergy treatment.